FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Waldencast plc Stock AnalysisComprehensive stock analysis for Waldencast plc (WALDW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisWALDW
WALDW
Waldencast plc
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
WALDW
Home🔹Stocks🔹Waldencast plc

Waldencast plc

WALDW•NASDAQ

Waldencast plc

WALDW•NASDAQ
Market cap
$167.35M
Sentiment

Your view on WALDW

Mkt Cap
$167.35M
Sentiment
Your view
WALDW
Waldencast plc
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
WALDW
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Waldencast plc

Industry
Household & Personal Products
Sector
Consumer Defensive
CEO
Michel Brousset
Headquarters
81 Fulham Road, London, NY, GB
Industry
Household & Personal Products
Sector
Consumer Defensive
CEO
Michel Brousset
Headquarters
81 Fulham Road, London, NY, GB
Description

Waldencast plc specializes in sophisticated skincare solutions, offering advanced treatments designed to diminish the appearance of premature aging, alleviate skin damage, correct hyperpigmentation, manage acne, and mitigate the effects of sun exposure. These products are predominantly distributed through a professional network that includes dermatologists, plastic surgeons, medical spas, and other certified skincare experts. The company's portfolio features Obagi Medical, a line of transformative skincare products formulated to visibly reduce signs of aging, target issues such as dark spots, uneven pigmentation, fine lines, and wrinkles, while simultaneously safeguarding and enhancing overall skin tone and texture. Additionally, Obagi Clinical provides skincare offerings specifically developed to proactively prevent the onset of early aging symptoms. Established in 1988, the company is based in White Plains, New York.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

FRC's fair value estimate for Waldencast plc, and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Waldencast plc. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Waldencast plc. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Waldencast plc. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Waldencast plc. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Waldencast plc valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Which institutions hold Waldencast plc, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

Buying and selling by Waldencast plc executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Waldencast plc. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Waldencast plc. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Waldencast plc. Press releases and market coverage, newest first.

News

Latest Market News